The expression of Nrf2 in DLBCL tissues is significantly higher than that in reactive lymph node hyperplasia tissues, and its expression level is significantly correlated with IPI and Ann-Arbor clinical stage (p < 0.05) (Yi et al., 2018). Here, NFE2L2 is linked to diffuse large B-cell lymphoma.